Obesity significantly increases loading forces on the knees, hips, ankles, and spine, accelerating cartilage degradation and contributing to osteoarthritis development and progression
The results demonstrated a dose-dependent effect on weight loss, with the maximum reduction reaching 14.7%, compared to only 2.3% in the placebo group
By indication, the obesity and weight management segment held a 28% share of the market in 2025 and is expected to grow at the fastest CAGR of 18.6% during the projection period
Because they slow digestion, GLP-1 drugs may interact with some medications and make them not work as well
According to NICE guidance (NG28) , GLP-1 agonists are recommended for type 2 diabetes when metformin and other treatments have not achieved adequate control